Clinical Trial Update: Monocyte Chemoattractant Protein-1 2518A/G Polymorphism

View source ↗

Summary

The trial evaluated the Monocyte Chemoattractant Protein-1 (MCP-1) 2518A/G polymorphism in individuals with Diabetic Retinopathy and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Snippet

Sponsor: Harbin Medical University | Conditions: Diabetic Retinopathy | Status: COMPLETED